Despite remarkable improvements in its diagnosis, prevention, and treatment,
cytomegalovirus (CMV) remains the single most important pathogen after solid organ …

Cytomegalovirus (CMV) has been recognized as one of the most important opportunistic
pathogens in transplant recipients. Direct clinical syndromes due to CMV are associated …

Late cytomegalovirus (CMV) disease is a well-described clinical problem after solid organ
transplantation in the era of universal prophylaxis with ganciclovir and valganciclovir [1–3] …

BACKGROUND: Late-onset CMV disease is being increasingly recognized as a significant
post-transplantation complication. OBJECTIVES: To discern the impact of antiviral …

Cytomegalovirus (CMV) is one of the most important pathogens following solid-organ
transplantation, and effective prevention of CMV infection is a priority. The long-term control …

Different approaches have been used to mitigate the morbidity and mortality associated with
cytomegalovirus (CMV) infection after solid organ transplantation [1]. Agents such as CMV …

To the Editor—Legendre et al.[1] address an important and topical issue—namely, late-
onset cytomegalovirus (CMV) disease in transplant recipients who receive antiviral …

Background Cytomegalovirus (CMV) disease typically occurs during the first year after solid
organ transplantation, after cessation of antiviral prophylaxis. CMV occurring after the first …

We assessed the impact of antiviral prophylaxis and preemptive therapy on the incidence
and outcomes of cytomegalovirus (CMV) disease in a nationwide prospective cohort of solid …

Cytomegalovirus (CMV) is the single most important pathogen affecting solid organ
transplant (SOT) recipients. CMV may occur as a primary infection in CMV-naïve patients …